References
- Memon AR, Shafique K, Memon A, Draz AU, Rauf M, Afsar S. Hepatitis B and C prevalence among the high risk groups of Pakistani population. A cross sectional study. Arch Public Health. 2012; 70:9. 10.1186/0778-7367-70-9.22958798
- Ali M, Idrees M, Ali L, Hussain A, Rehman IU, Saleem S, et al. Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes. Virol J. 2011; 8:102. 10.1186/1743-422X-8-102.21375760
- Hakim S, Kazmi S, Bagasra O. Seroprevalence of hepatitis B and C genotypes among young apparently healthy females of Karachi-Pakistan. Libyan J Med. 2008; 3:66-70.10.3402/ljm.v3i2.476021499460
- Taseer IU, Ishaq F, Hussain L, Safdar S, Mirbahar AM, Faiz SA. Frequency of anti-HCV, HBsAg and related risk factors in pregnant women at Nishtar Hospital, Multan. J Ayub Med Coll Abbottabad. 2010; 22:13-6.21409894
- Liaw Y-F, Kao J-H, Piratvisuth T, Chan HLY, Chien RN, Liu C-J, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012; 6:531-61.2620146910.1007/s12072-012-9365-4
- Singhal V, Bora D, Singh S. Hepatitis B in health care workers: Indian scenario. J Lab Physicians. 2009; 1: 41-8.2193824810.4103/0974-2727.59697
- Attaullah S, Khan S, Naseemullah AS, Khan SN, Ali I, Hoti N, et al. Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan. Virol J. 2011; 8:275. 10.1186/1743-422X-8-275.21645287
- Tacke F, Manns MP, Trautwein C. Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance – implications for novel antiviral strategies. Curr Med Chem. 2004; 11:2667-77.10.2174/092986704336433315544468
- Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology. 2003; 125:444-51.1289154710.1016/S0016-5085(03)00895-3
- Khokhar N, Gill ML. Serological profile of incidentally detected asymptomatic HBsAg positive subjects (IDAHS). J Coll Physicians Surg Pak. 2004; 14:208-10.15228822
- Hussain AB, Tairq WZ, Anwar M, Waqar A. Anti-HBe positive Hepatitis B virus carriers with detectable HBV DNA. Pak J Gastroenterol. 2006; 20:1-5.
- Mumtaz K, Hamid S, Ahmed S, Moatter T, Mushtaq S, Khan A, et al. A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan: HBV genotypes in Pakistan. Hepat Mon. 2011; 11: 14-8.22087110
- Alam S, Ahmad N, Mustafa G, Alam K, Khan M. Characteristics of treatment naive chronic hepatitis B in Bangladesh: younger populations are more affected; HBeAg-negatives are more advanced. Saudi J Gastroenterol. 2008; 14:15-9.10.4103/1319-3767.3779619568488
- Ahmad N, Alam S, Mustafa G, Adnan A, Baig RH, Khan M. e-antigen-negative chronic hepatitis B in Bangladesh. Hepatobiliary Pancreat Dis Int. 2008; 7: 379-82.18693173
- Chan HL, Leung NW, Hussain M, Wong ML, Lok AS. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology. 2000; 31:763-8.10.1002/hep.510310330
- Yoo BC, Park J-W, Kim HJ, Lee DH, Cha YJ, Park SM. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol. 2003; 38:98-103.10.1016/S0168-8278(02)00349-5
- Rabbi FJ, Rezwan MK, Shirin T. HBeAg/anti-HBe, alanine aminotransferase and HBV DNA. Bangladesh Med Res Counc Bull. 2008; 34:39-43.19119537
- Ljunggren KK, Nordenfelt E, Kidd A. Correlation of HBeAg/anti HBe, ALT levels, and HBV DNA PCR results in HBsAg positive patients. J Med Virol. 1993; 39:297-302.10.1002/jmv.18903904088492102
- Pinho J, Santos CAdST, Gonzalez C, Bassit L, Barreto C, Saez-Alquezar A, et al. Detection of hepatitis B virus DNA by the polymerase chain reaction in anti-HBe positive chronic hepatitis B patients. Rev Inst Med Trop Sao Paulo. 1993; 35: 515-20.799775510.1590/S0036-46651993000600007
- Ankouane F, Kowo M, Njoya O, Ndam ECN. High frequency of HBeAg-negative cases in naive HBsAg-positive subjects with chronic hepatitis B virus infection managed in the Yaoundé Hepatitis Therapeutic Committee: a cross sectional study. Open J Epidemiol. 2015; 5:113.10.4236/ojepi.2015.52015
- Qureshi H, Javaid N, Alam SE, Bile KM. The evidence of mother to child transmission of hepatitis B virus infection in Pakistan and the need for hepatitis B immunization policy change. J Pak Med Assoc. 2014; 64:403-8.24864633
- Knöll A, Rohrhofer A, Kochanowski B, Wurm EM, Jilg W. Prevalence of precore mutants in anti HBe positive hepatitis B virus carriers in Germany. J Med Virol. 1999; 59:14-8.1044080210.1002/(SICI)1096-9071(199909)59:1<;14::AID-JMV3>3.0.CO;2-T
- Badur S, Akgün A. Diagnosis of hepatitis B infections and monitoring of treatment. J Clin Virol. 2001; 21: 229-37.1139765910.1016/S1386-6532(01)00147-0
- Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006; 130:678-86.10.1053/j.gastro.2005.11.01616530509
- Baig S, Siddiqui A, Chakravarty R, Moatter T. Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Res Notes. 2009; 2:1. 10.1186/1756-0500-2-1.19121226